Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Plc Regulatory News (EML)

Share Price Information for Emmerson Plc (EML)

Share Price is delayed by 15 minutes
Get Live Data
2.10    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £28.06m
EML Live PriceLast checked at - London Stock Exchange

Intraday Emmerson Plc Share Chart

Request for Arbitration

1 May 2025 08:10

RNS Number : 0138H
Emmerson PLC
01 May 2025
 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

 

1 May 2025

Emmerson PLC

("Emmerson" or the "Company")

Emmerson Submits Request for Arbitration

Emmerson Plc, the Moroccan focused potash development company, is pleased to provide an update on the dispute with the Kingdom of Morocco in relation to the Khemisset Potash Project in Morocco (the "Project").

· A Request for Arbitration (RFA) has been submitted to the International Centre for Settlement of Investment Disputes (ICSID), an arm of the World Bank with regard to various breaches, by the Government of the Kingdom of Morocco and its Agents, of the Agreement between the Government of the United Kingdom of Great Britain and Northern Ireland and the Government of the Kingdom of Morocco for the Promotion and Protection of Investments, which was signed on 30 October 1990 and entered into force on 14 February 2002 (the "BIT").

·  Emmerson is bringing a claim for full compensation in respect of the Khemisset Potash Project which it had internally valued at $2.2 billion.

·  All the legal costs in relation to the matter as well as a significant portion of G&A costs are to be funded through the $11.2 million litigation funding facility confirmed in January 2025.

· Emmerson, through the Company's legal advisors Boies Schiller Flexner (BSF), are working on the formation of the arbitral tribunal and preparing a formal Memorial submission.

The Request for Arbitration and Next Steps

The lodging of the RFA with ICSID is the first formal step in the arbitration process.

Once the RFA is received by ICSID, copies are to be sent to all relevant parties in the case, being the appropriate people within the Government of the Kingdom of Morocco.

The RFA itself is a document that lays out the general background and details of the case in relation to Morocco's expropriation of the Project. In due course, the Company will make further announcements concerning the constitution of the arbitral tribunal, the filing of written submissions, including a substantiated damages figure, and the evidentiary hearing, which the Company understands will take approximately two years from the submission of the RFA.

Graham Clarke, Managing Director of Emmerson PLC commented:

"The completion and lodgement of the RFA with ICSID is a significant step and marks the formal commencement of the litigation process. The Company is working closely with our lawyers at BSF and as a group we remain confident in the merits of this case. We look forward to providing further updates in due course".

 

**ENDS**

For further information, please visit www.emmersonplc.com, follow us on Twitter

(@emmerson_plc),

or contact: 

Emmerson Plc

Graham Clarke / Hayden Locke

+44 (0) 207 138 3204

Panmure Liberum Limited (Nominated Adviser and Broker)

Scott Mathieson / Will King

+44 (0) 20 3100 2000

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDFLBBEELBBBD
Date   Source Headline
30th Mar 20267:00 amRNSArbitration Memorial Submission
24th Mar 20267:00 amRNSResult of WRAP Retail Offer
20th Mar 20267:31 amRNSWRAP Retail Offer for up to £100,000
20th Mar 20267:30 amRNSResult of Placing and Subscription
20th Mar 20267:00 amRNSProposed Placing and Subscription
22nd Jan 20267:00 amRNSArbitration Update
26th Nov 20257:00 amRNSAppointment of Joint Broker
30th Sep 20257:00 amRNSInterim Results
24th Jul 202512:31 pmRNSResult of Annual General Meeting
1st Jul 20257:00 amRNSNotice of AGM
30th Jun 20253:36 pmRNS2024 Financial Results
1st May 20258:10 amRNSRequest for Arbitration
17th Mar 20257:00 amRNSLitigation Funding Update
13th Jan 20253:03 pmRNSAdditional Issuance of Shares and Rights
2nd Jan 20257:00 amRNSLitigation Funding Secured
12th Dec 20247:00 amRNSAdditional Issuance of Shares and Rights
6th Dec 20247:01 amRNSFundraising of £0.85 million
1st Nov 20247:00 amRNSNotice of dispute with Moroccan Government
28th Oct 20247:00 amRNSESIA Process, Board Changes, and Cash Management
14th Oct 20247:00 amRNSESIA Update
27th Sep 20247:00 amRNSInterim Results and Q3 Update
5th Jul 20247:00 amRNSQ2 Update
1st Jul 20247:00 amRNSChange of Nominated Advisor and Joint Broker
26th Jun 202411:33 amRNSResult of Annual General Meeting
31st May 202410:56 amRNSGrant of Share Options and PDMR dealing
31st May 20247:00 amRNSNotice of AGM and Posting of Annual Report
24th May 20247:00 amRNS2023 Financial Results
22nd Apr 202411:47 amRNSTR-1: Notification of major holdings
8th Apr 20244:45 pmRNSResults of Oversubscribed REX Retail Offer
8th Apr 20247:01 amRNSREX Retail Offer
8th Apr 20247:00 amRNSQ1 Update, Equity Placing and Retail Offer
11th Mar 20247:00 amRNSCommittee Upholds Environmental Approval Referral
1st Feb 20247:00 amRNSScoping Study on Breakthrough New Processing Route
8th Jan 20247:00 amRNSQ4 Update
21st Dec 20237:00 amRNSExtension of Mandated Lead Arrangers
26th Sep 20237:00 amRNSInterim Results for the six months to 30 June 2023
21st Sep 20237:00 amRNSQ3 2023 and Financing update
11th Sep 202311:38 amRNSMorocco Statement
11th Jul 202311:57 amRNSDirector/PDMR Shareholding
10th Jul 20234:30 pmRNSDirector/PDMR Shareholding
6th Jul 20232:49 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSQ2 Update
6th Jun 20237:00 amRNSExercise & Allotment of Shares
31st May 202312:01 pmRNSResult of AGM
5th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20237:00 amRNS2022 Financial Results and Q1 Update
14th Feb 20237:00 amRNSMandated Lead Arrangers Appointed for Financing
9th Jan 20237:00 amRNSQ4 Update
3rd Jan 20237:00 amRNSAppointment of Liberum as Nominated Advisor
21st Nov 20227:00 amRNSPotash and Salt Offtake MOUs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.